nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.127	0.224	CbGbCtD
Sulfamethoxazole—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0929	0.163	CbGbCtD
Sulfamethoxazole—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0889	0.156	CbGbCtD
Sulfamethoxazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0556	0.0978	CbGbCtD
Sulfamethoxazole—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0536	0.0943	CbGbCtD
Sulfamethoxazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0517	0.0909	CbGbCtD
Sulfamethoxazole—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0381	0.067	CbGbCtD
Sulfamethoxazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0237	0.0417	CbGbCtD
Sulfamethoxazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0217	0.0383	CbGbCtD
Sulfamethoxazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0148	0.0261	CbGbCtD
Sulfamethoxazole—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000506	0.00117	CcSEcCtD
Sulfamethoxazole—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000506	0.00117	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000505	0.00117	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000505	0.00117	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.0005	0.00116	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000498	0.00116	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000498	0.00115	CcSEcCtD
Sulfamethoxazole—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00115	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000494	0.00114	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000493	0.00114	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.00114	CcSEcCtD
Sulfamethoxazole—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000492	0.00114	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000491	0.00114	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.00113	CcSEcCtD
Sulfamethoxazole—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000488	0.00113	CcSEcCtD
Sulfamethoxazole—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000488	0.00113	CcSEcCtD
Sulfamethoxazole—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000487	0.00113	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.00113	CcSEcCtD
Sulfamethoxazole—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.00112	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.00112	CcSEcCtD
Sulfamethoxazole—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000482	0.00112	CcSEcCtD
Sulfamethoxazole—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00048	0.00111	CcSEcCtD
Sulfamethoxazole—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000479	0.00111	CcSEcCtD
Sulfamethoxazole—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.00111	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000477	0.0011	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000477	0.0011	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000476	0.0011	CcSEcCtD
Sulfamethoxazole—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000473	0.0011	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.00109	CcSEcCtD
Sulfamethoxazole—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000469	0.00109	CcSEcCtD
Sulfamethoxazole—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000469	0.00109	CcSEcCtD
Sulfamethoxazole—Rash—Topotecan—peripheral nervous system neoplasm	0.000469	0.00109	CcSEcCtD
Sulfamethoxazole—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000468	0.00109	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000468	0.00109	CcSEcCtD
Sulfamethoxazole—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000468	0.00108	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000467	0.00108	CcSEcCtD
Sulfamethoxazole—Cough—Etoposide—peripheral nervous system neoplasm	0.000467	0.00108	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000466	0.00108	CcSEcCtD
Sulfamethoxazole—Headache—Topotecan—peripheral nervous system neoplasm	0.000466	0.00108	CcSEcCtD
Sulfamethoxazole—Rash—Tretinoin—peripheral nervous system neoplasm	0.000465	0.00108	CcSEcCtD
Sulfamethoxazole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000465	0.00108	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000465	0.00108	CcSEcCtD
Sulfamethoxazole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000465	0.00108	CcSEcCtD
Sulfamethoxazole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000465	0.00108	CcSEcCtD
Sulfamethoxazole—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000464	0.00108	CcSEcCtD
Sulfamethoxazole—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000463	0.00107	CcSEcCtD
Sulfamethoxazole—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000463	0.00107	CcSEcCtD
Sulfamethoxazole—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000463	0.00107	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.00107	CcSEcCtD
Sulfamethoxazole—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000462	0.00107	CcSEcCtD
Sulfamethoxazole—Headache—Tretinoin—peripheral nervous system neoplasm	0.000462	0.00107	CcSEcCtD
Sulfamethoxazole—Rash—Melphalan—peripheral nervous system neoplasm	0.000459	0.00106	CcSEcCtD
Sulfamethoxazole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000459	0.00106	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.00106	CcSEcCtD
Sulfamethoxazole—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000454	0.00105	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000452	0.00105	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000448	0.00104	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000444	0.00103	CcSEcCtD
Sulfamethoxazole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000444	0.00103	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.00102	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.00102	CcSEcCtD
Sulfamethoxazole—Nausea—Topotecan—peripheral nervous system neoplasm	0.000442	0.00102	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000441	0.00102	CcSEcCtD
Sulfamethoxazole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00102	CcSEcCtD
Sulfamethoxazole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00102	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000436	0.00101	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000434	0.00101	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.001	CcSEcCtD
Sulfamethoxazole—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000433	0.001	CcSEcCtD
Sulfamethoxazole—Nausea—Melphalan—peripheral nervous system neoplasm	0.000433	0.001	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000427	0.00099	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000987	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000426	0.000987	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000426	0.000987	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000425	0.000984	CcSEcCtD
Sulfamethoxazole—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000424	0.000982	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000977	CcSEcCtD
Sulfamethoxazole—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000416	0.000964	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000961	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000414	0.00096	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000413	0.000956	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000412	0.000955	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000411	0.000953	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000947	CcSEcCtD
Sulfamethoxazole—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000932	CcSEcCtD
Sulfamethoxazole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000401	0.00093	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000397	0.00092	CcSEcCtD
Sulfamethoxazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.000917	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000913	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00091	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000904	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000389	0.000902	CcSEcCtD
Sulfamethoxazole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000387	0.000896	CcSEcCtD
Sulfamethoxazole—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000894	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000889	CcSEcCtD
Sulfamethoxazole—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000889	CcSEcCtD
Sulfamethoxazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000383	0.000888	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000383	0.000886	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000881	CcSEcCtD
Sulfamethoxazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00038	0.000881	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000379	0.000879	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000876	CcSEcCtD
Sulfamethoxazole—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000874	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000377	0.000873	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000377	0.000873	CcSEcCtD
Sulfamethoxazole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000376	0.000872	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000871	CcSEcCtD
Sulfamethoxazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000866	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000863	CcSEcCtD
Sulfamethoxazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.000857	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000369	0.000854	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000842	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000841	CcSEcCtD
Sulfamethoxazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.00083	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000829	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000827	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000357	0.000827	CcSEcCtD
Sulfamethoxazole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000356	0.000826	CcSEcCtD
Sulfamethoxazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000355	0.000824	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000822	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000822	CcSEcCtD
Sulfamethoxazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.000817	CcSEcCtD
Sulfamethoxazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.000816	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000815	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000351	0.000813	CcSEcCtD
Sulfamethoxazole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.000812	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000808	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000806	CcSEcCtD
Sulfamethoxazole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000347	0.000803	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000802	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000345	0.000799	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000345	0.000799	CcSEcCtD
Sulfamethoxazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000798	CcSEcCtD
Sulfamethoxazole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000343	0.000794	CcSEcCtD
Sulfamethoxazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000342	0.000792	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000788	CcSEcCtD
Sulfamethoxazole—Rash—Vincristine—peripheral nervous system neoplasm	0.00034	0.000787	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000339	0.000786	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000784	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000782	CcSEcCtD
Sulfamethoxazole—Headache—Vincristine—peripheral nervous system neoplasm	0.000338	0.000782	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000778	CcSEcCtD
Sulfamethoxazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00077	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000767	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000326	0.000755	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000754	CcSEcCtD
Sulfamethoxazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000746	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000322	0.000745	CcSEcCtD
Sulfamethoxazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000744	CcSEcCtD
Sulfamethoxazole—Nausea—Vincristine—peripheral nervous system neoplasm	0.00032	0.000742	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000738	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000729	CcSEcCtD
Sulfamethoxazole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000313	0.000726	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000725	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000724	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000721	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000719	CcSEcCtD
Sulfamethoxazole—Chills—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000716	CcSEcCtD
Sulfamethoxazole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000309	0.000715	CcSEcCtD
Sulfamethoxazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000303	0.000702	CcSEcCtD
Sulfamethoxazole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000699	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000698	CcSEcCtD
Sulfamethoxazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.0003	0.000696	CcSEcCtD
Sulfamethoxazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.0003	0.000695	CcSEcCtD
Sulfamethoxazole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000695	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000299	0.000692	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00069	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000688	CcSEcCtD
Sulfamethoxazole—Tension—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000682	CcSEcCtD
Sulfamethoxazole—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000675	CcSEcCtD
Sulfamethoxazole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000289	0.000669	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000667	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000665	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000662	CcSEcCtD
Sulfamethoxazole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000283	0.000656	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000647	CcSEcCtD
Sulfamethoxazole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000277	0.000643	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000643	CcSEcCtD
Sulfamethoxazole—Rash—Etoposide—peripheral nervous system neoplasm	0.000275	0.000638	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000275	0.000637	CcSEcCtD
Sulfamethoxazole—Headache—Etoposide—peripheral nervous system neoplasm	0.000273	0.000634	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000631	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000624	CcSEcCtD
Sulfamethoxazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000624	CcSEcCtD
Sulfamethoxazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000622	CcSEcCtD
Sulfamethoxazole—Cough—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000606	CcSEcCtD
Sulfamethoxazole—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000602	CcSEcCtD
Sulfamethoxazole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000259	0.000601	CcSEcCtD
Sulfamethoxazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000591	CcSEcCtD
Sulfamethoxazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000591	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000587	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000577	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000575	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000567	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000561	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000557	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000556	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000555	CcSEcCtD
Sulfamethoxazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000551	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000547	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000547	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000543	CcSEcCtD
Sulfamethoxazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00054	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000525	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000516	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000514	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000514	CcSEcCtD
Sulfamethoxazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000513	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000509	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000505	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.0005	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000499	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000493	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000489	CcSEcCtD
Sulfamethoxazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000489	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000478	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000474	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000468	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000464	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000462	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000456	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000453	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000452	CcSEcCtD
Sulfamethoxazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00045	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000448	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000448	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000429	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000418	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000417	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000415	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000415	CcSEcCtD
Sulfamethoxazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000407	CcSEcCtD
Sulfamethoxazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000401	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000388	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000386	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000376	CcSEcCtD
Sulfamethoxazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000375	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000371	CcSEcCtD
Sulfamethoxazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00036	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000359	CcSEcCtD
Sulfamethoxazole—Rash—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000357	CcSEcCtD
Sulfamethoxazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000357	CcSEcCtD
Sulfamethoxazole—Headache—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000355	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000347	CcSEcCtD
Sulfamethoxazole—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000337	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000333	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000331	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00033	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000329	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000312	CcSEcCtD
